AI Article Synopsis
- The study investigates how raloxifene and estradiol affect osteoblasts, focusing on their proliferation, differentiation, and osteoprotegerin expression.
- Raloxifene showed no significant impact on osteoblast proliferation or osteoprotegerin expression but did enhance alkaline phosphatase activity, indicating some positive effect on bone forming activity.
- In contrast, estradiol significantly boosted osteoblast proliferation, differentiation, mineralization, and osteoprotegerin expression, highlighting its more beneficial role in bone health compared to raloxifene.
Article Abstract
Objective: To study the effect of raloxifene and estradiol on the biological function and osteoprotegerin expression of osteoblasts in vitro.
Methods: Different doses of raloxifene and estradiol were added into the medium of the second generation osteoblasts from the shull of newborn SD rats. The proliferation, differentiation, mineralization and osteoprotegerin expression of the osteoblasts in different groups were observed.
Results: Raloxifene had no significant effects on stimulating the proliferation, the expression of osteoprotegerin and the formation of mineral nodes of the cultured osteoblasts (the trial vs the control, P>0.05). However, raloxifene can significantly improve the alkaline phosphatase activity of the cultured osteoblasts (the trial vs the control, P<0.05). Estradiol significantly increased the proliferation of osteoblasts, and differentiation, mineralization, expression of osteoprotegerin (P<0.01 vs the control).
Conclusion: The effects of raloxifene and estradiol on the cultured osteoblasts are different, which implied their different mechanisms in inducing osteoporosis.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!